128 related articles for article (PubMed ID: 1293049)
1. Cerebrospinal fluid neopterin and beta 2-microglobulin levels in neurologically asymptomatic HIV-infected patients before and after initiation of zidovudine treatment.
Hagberg L; Norkrans G; Andersson M; Wachter H; Fuchs D
Infection; 1992; 20(6):313-5. PubMed ID: 1293049
[TBL] [Abstract][Full Text] [Related]
2. Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study.
Gisslén M; Chiodi F; Fuchs D; Norkrans G; Svennerholm B; Wachter H; Hagberg L
Scand J Infect Dis; 1994; 26(5):523-33. PubMed ID: 7855550
[TBL] [Abstract][Full Text] [Related]
3. Effect of zidovudine on cerebrospinal fluid in patients with HIV infection and acute neurological disease.
Hagberg L; Andersson M; Chiodi F; Fuchs D; Svennerholm B; Wachter H; Norkrans G
Scand J Infect Dis; 1991; 23(6):681-5. PubMed ID: 1815328
[TBL] [Abstract][Full Text] [Related]
4. The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine.
Gisslén M; Norkrans G; Svennerholm B; Hagberg L
J Infect Dis; 1997 Feb; 175(2):434-7. PubMed ID: 9203666
[TBL] [Abstract][Full Text] [Related]
5. Effect of antiretroviral therapy on the cerebrospinal fluid of patients seropositive for the human immunodeficiency virus.
Gulevich SJ; McCutchan JA; Thal LJ; Kirson D; Durand D; Wallace M; Mehta P; Heyes MP; Grant I
J Acquir Immune Defic Syndr (1988); 1993 Sep; 6(9):1002-7. PubMed ID: 8101873
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal immunoactivation in patients with HIV-1 infection is reduced by zidovudine but not by didanosine.
Hagberg L; Norkrans G; Gisslen M; Wachter H; Fuchs D; Svennerholm B
Scand J Infect Dis; 1996; 28(4):329-33. PubMed ID: 8893393
[TBL] [Abstract][Full Text] [Related]
7. Expansion of neopterin and beta 2-microglobulin in cerebrospinal fluid reaches maximum levels early and late in the course of human immunodeficiency virus infection.
Bogner JR; Junge-Hülsing B; Kronawitter U; Sadri I; Matuschke A; Goebel FD
Clin Investig; 1992 Aug; 70(8):665-9. PubMed ID: 1392442
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid neopterin levels in 159 neurologically asymptomatic persons infected with the human immunodeficiency virus (HIV-1): relationship to immune status.
Lucey DR; McGuire SA; Abbadessa S; Hall K; Woolford B; Valtier S; Butzin CA; Melcher GP; Hendrix CW
Viral Immunol; 1993; 6(4):267-72. PubMed ID: 7909441
[TBL] [Abstract][Full Text] [Related]
9. The effect of zidovudine treatment on serum neopterin and beta 2-microglobulin levels in mildly symptomatic, HIV type 1 seropositive individuals.
Bass HZ; Hardy WD; Mitsuyasu RT; Taylor JM; Wang YX; Fischl MA; Spector SA; Richman DD; Fahey JL
J Acquir Immune Defic Syndr (1988); 1992; 5(3):215-21. PubMed ID: 1346807
[TBL] [Abstract][Full Text] [Related]
10. Neopterin and beta 2-microglobulin and the assessment of intra-blood-brain-barrier synthesis of HIV-specific and total IgG.
Peter JB; McKeown KL; Barka NE; Tourtellotte WW; Singer EJ; Syndulko K
J Clin Lab Anal; 1991; 5(5):317-20. PubMed ID: 1941351
[TBL] [Abstract][Full Text] [Related]
11. Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2-microglobulin and neopterin.
Brew BJ; Dunbar N; Pemberton L; Kaldor J
J Infect Dis; 1996 Aug; 174(2):294-8. PubMed ID: 8699058
[TBL] [Abstract][Full Text] [Related]
12. Increase of tryptophan in serum and in cerebrospinal fluid of patients with HIV infection during zidovudine therapy.
Fuchs D; Gisslén M; Larsson M; Norkrans G; Hagberg L; Wachter H
Adv Exp Med Biol; 1996; 398():131-4. PubMed ID: 8906255
[TBL] [Abstract][Full Text] [Related]
13. Elevated neopterin and beta 2-microglobulin levels in blood and cerebrospinal fluid occur early in HIV-1 infection.
Sönnerborg AB; von Stedingk LV; Hansson LO; Strannegård OO
AIDS; 1989 May; 3(5):277-83. PubMed ID: 2504231
[TBL] [Abstract][Full Text] [Related]
14. Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients.
Heyes MP; Brew BJ; Saito K; Quearry BJ; Price RW; Lee K; Bhalla RB; Der M; Markey SP
J Neuroimmunol; 1992 Sep; 40(1):71-80. PubMed ID: 1387655
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of soluble CD8, neopterin, beta 2-microglobulin and p24 antigen as indicators of disease progression in children with AIDS on zidovudine therapy.
Siller L; Martin NL; Kostuchenko P; Beckett L; Rautonen J; Cheng SC; Wara DW
AIDS; 1993 Mar; 7(3):369-73. PubMed ID: 8097095
[TBL] [Abstract][Full Text] [Related]
16. Tryptophan concentrations increase in cerebrospinal fluid and blood after zidovudine treatment in patients with HIV type 1 infection.
Gisslén M; Larsson M; Norkrans G; Fuchs D; Wachter H; Hagberg L
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):947-51. PubMed ID: 7529033
[TBL] [Abstract][Full Text] [Related]
17. Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1 infection.
Abdulle S; Hagberg L; Svennerholm B; Fuchs D; Gisslén M
AIDS; 2002 Nov; 16(16):2145-9. PubMed ID: 12409735
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid neopterin concentrations in central nervous system infection.
Hagberg L; Dotevall L; Norkrans G; Larsson M; Wachter H; Fuchs D
J Infect Dis; 1993 Nov; 168(5):1285-8. PubMed ID: 8228365
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection.
Brew BJ; Bhalla RB; Paul M; Gallardo H; McArthur JC; Schwartz MK; Price RW
Ann Neurol; 1990 Oct; 28(4):556-60. PubMed ID: 2252366
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of combined response markers among human immunodeficiency virus-infected persons: possible aid in the decision to change zidovudine monotherapy.
Graham NM; Park LP; Piantadosi S; Phair JP; Mellors J; Fahey JL; Saah AJ
Clin Infect Dis; 1995 Feb; 20(2):352-62. PubMed ID: 7742442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
